JPRN-UMIN000016377已完成1 期
Phase 1 study of TS-1 with Abraxane for metastatic breast cancer - TS-1/ABI Phase 1 study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)had a previous allergy for TS-1 or Abraxane 2)be pregnant or possible to pregnancy 3)with active breast cancer 4)with severe complications 5)with uncontrolled pleural effusion,ascites and edema 6)with brain metastasis 7)doctor's decision not to be registered to this study
研究者
相似试验
尚未招募
1 期
Phase I and dose-finding study of TS-1 with Abraxane for metastatic breast cancermetastatic breast cancerJPRN-UMIN000006383Tokusima University Hospital12
已完成
2 期
Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancerliver metastases of colorectal cancerJPRN-UMIN000001498agoya Surgical Oncology Group60
终止
1 期
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckSquamous Cell Carcinoma of the Head and NeckBasaloid Squamous Cell CarcinomaAdenosquamous Cell CarcinomaUndifferentiated CarcinomaNCT00570674Dana-Farber Cancer Institute29
招募中
不适用
Phase I open label trial of Abraxane (nab-paclitaxel) administered concurrently with radiotherapy in patients with locally advanced inoperable pancreatic adenocarcinoma.ACTRN12613001013752Southern Adelaide Local Health Network15
暂停
不适用
A phase I study of TS-1 and docetaxel for advanced gastric cancerJPRN-C000000188Department of Medical Oncology, Kinki University School of Medicine15